Article in Clinical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
24 authors.
Maísa Ganz Sanchez SennesInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0009-0007-6136-1925
Laura Machado Lara CarvalhoInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0001-5599-2236
Matheus Augusto Araújo CastroInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0003-0335-8799
Giovana Manilli ToccoliDepartment of Morphology and Genetics, Federal University of Sao Paulo, São Paulo, Brazil.
Sofia de Oliveira FariasInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0002-9105-1692
Davi Mendes Campo FialhoInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0002-0483-8797
Eny Maria Goloni BertolloFaculty of Medicine of Sao José do Rio Preto, São José do Rio Preto, Brazil.ORCID 0000-0002-2622-4673
Erika Cristina PavarinoFaculty of Medicine of Sao José do Rio Preto, São José do Rio Preto, Brazil.ORCID 0000-0003-0959-0695
Larissa Sampaio de AthaydeUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Mendelics Genomic Analysis, São Paulo, Brazil.
Maria Betânia Pereira TorallesFaculty of Medicine, Federal University of Bahia, Salvador, Brazil.
Maria Isabel MelaragnoDepartment of Morphology and Genetics, Federal University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0002-4344-9698
Mariluce Riegel-GiuglianiCasa dos Raros, Center for Comprehensive Care and Training in Rare Diseases, Anthony Daher Laboratory, Casa dos Raros, Porto Alegre, Brazil.ORCID 0000-0002-6397-1301
Gustavo Marquezani SpoladorUnit of Pediatric Pain and Palliative Care, Instituto da Criança, Clinics Hospital of University of Sao Paulo Faculty of Medicine, São Paulo, Brazil.
Paulo Alberto OttoInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0001-8810-6608
Caroline Brandão PiaiGenetics Unit, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Fernando KokUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Mendelics Genomic Analysis, São Paulo, Brazil.ORCID 0000-0002-7577-9122
Ceres Schmitz CechellaCechella Medical Clinic, Novo Hamburgo, Brazil.
Carla RosenbergInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0003-3253-4448
Juan Clinton LlerenaNational Institute Fernandes Figueira - Fiocruz, Rio de Janeiro, Brazil.
Débora Romeo BertolaGenetics Unit, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-4701-6777
Salmo RaskinPostgraduate Program in Child and Adolescent, Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil.
Chong Ae KimGenetics Unit, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-1754-1300
Ana Cristina Victorino KrepischiInstitute of Biosciences, Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, University of Sao Paulo, São Paulo, Brazil.ORCID 0000-0003-2931-8605
Funding
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES 88887.110909/2025-00; 88887.113708/2025-00Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP 2013/08028-1; 2022/03980-5; 2023/07389-2; 2023/16666-0; 2023/16839-1; 2023/09879-7
6 · The paper itself
Abstract
Xia-Gibbs syndrome (XGS) is a rare intellectual disability (ID) syndrome caused by de novo AHDC1 pathogenic variants. We characterized clinical and molecular features of 16 Brazilian patients with XGS. Patient data were collected through semistructured interviews with family members, reanalysis of previous health and genetic assessments, and clinical reports from physicians. Genomic variants and their segregation were validated via Sanger sequencing. Statistical analyses were conducted to evaluate genotype-phenotype associations. Twelve novel AHDC1 causative variants were documented. ID, hypotonia, motor developmental delay, and varied nonspecific facial dysmorphisms were observed in all patients, while speech impairment and autism spectrum disorder were present in nearly all. Three frequent phenotypes, not previously reported, were identified: hyperphagia/food obsession, genital/gonadal alterations in males, and shortening of the Achilles tendon. Additionally, our findings provide statistically significant support for previously reported genotype-phenotype associations between pathogenic variants in the first half of the AHDC1 coding region and the occurrence of epilepsy and scoliosis. We also propose a novel association between N-terminal variants and developmental regression. In summary, our results broaden the clinical phenotype of XGS, with musculoskeletal and genital/gonadal abnormalities highlighting the multisystem involvement in this condition, beyond neurodevelopmental deficits. Comprehensive phenotypic assessments in all identified XGS cases are recommended to accurately recognize and associate novel clinical signs with XGS.
Indexed as
Abnormalities, MultipleIntellectual DisabilityAdolescentAdultBrazilChildChild, PreschoolCohort StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansInfantMaleMutationPhenotypeAHDC1developmental regressiongonadal alterationshyperphagiaphenotypic spectrumshortening of the Achilles tendonXia–Gibbs syndrome
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clinical and Molecular Characterization of Xia-Gibbs Syndrome: Expanding the Phenotypic Spectrum in a Brazilian Cohort. · full record | OpenQuestion